Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on September 8, 2025
NYUAD researchers develop 3D-printed capsule to sample gut microbiome
EIN Presswire
·
September 8, 2025
CORAL capsule offers non-invasive access to understudied intestinal microbes ABU DHABI, ABU DHABI, UNITED ARAB EMIRATES, September 8, 2025 /EINPresswire.com/ -- Gut microbiome studies have long relied on fecal samples, which primarily represent microbes …
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
GlobeNewswire
·
September 8, 2025
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to …
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
GlobeNewswire
·
September 8, 2025
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved by the U.S. Food and Drug …
House of Doge Treasury Partner CleanCore Solutions Acquires 285,420,000 DOGE with Strategic Goal to Accumulate First Milestone Target of 1 Billion DOGE in 30 Days as the Newly Launched Official Dogecoin Treasury
GlobeNewswire
·
September 8, 2025
MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- House of Doge, the official corporate arm of the Dogecoin Foundation, together with their partner CleanCore Solutions, Inc. (NYSE American: ZONE) (“CleanCore” or “ZONE”), announced the successful acquisition of 285 …
PharmAla Completes Import of LaNeo MDMA for US Distribution
GlobeNewswire
·
September 8, 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
GlobeNewswire
·
September 8, 2025
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases, today announced that …
CompoSecure to Move Stock Exchange Listing to NYSE
GlobeNewswire
·
September 8, 2025
SOMERSET, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO) (“CompoSecure” or the “Company”) today announced that it will transfer the listing of its Class A common stock (Nasdaq: CMPO) to the New York Stock Exchange (“NYSE”) from …
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
GlobeNewswire
·
September 8, 2025
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are further supported by early data from open- …
Rapport Announces Proposed Public Offering of Common Stock
GlobeNewswire
·
September 8, 2025
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
GlobeNewswire
·
September 8, 2025
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …
Abivax Presents First Half 2025 Financial Results
GlobeNewswire
·
September 8, 2025
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
GlobeNewswire
·
September 8, 2025
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives …
Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
GlobeNewswire
·
September 8, 2025
In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic designed to restore critical gut microbes in babies. The milestone underscores the urgent demand for solutions that support healthy immune …
Easy Edge Index: Why Easy Edge Index Is Becoming the Core of AI-Based Trading Platform – Read Australia Easy Edge Index Trading App Report!
GlobeNewswire
·
September 8, 2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- What Is Easy Edge Index? Introduction to AI-Driven Trading in 2025 Easy Edge Index has positioned itself at the forefront of financial technology, providing a modernized framework for trading that …
Abdul Qavi Publishes Op-Ed on Agentic AI and Product Leadership in the GCC
EIN Presswire
·
September 8, 2025
A Rasmal op-ed by Abdul Qavi outlines how agentic AI can move the GCC beyond apps to outcome-driven assistants, with clear guidance for product teams. DOHA, QATAR, September 8, 2025 /EINPresswire.com/ -- A recent opinion piece by Abdul Qavi, Product …
New Webcast Series by AI/R Company Subsidiary Everymind Highlights Real-World Use Cases of Generative AI and Automation with Agentforce
GlobeNewswire
·
September 8, 2025
SAN FRANCISCO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sharing real stories and insights about the application of AI, GenAI, and automation with Agentforce in clients. This is the goal of the new webcast Transform AI, created by Everymind, a subsidiary of AI/R …
High-power AEM Interpretation Highlights
GlobeNewswire
·
September 8, 2025
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- ZEB Nickel Corp. (ZBNI:TSX-V) (OTC:ZBNIF) (“Zeb” or the “Company”) ZEB Nickel Corp (“ZEB” or the “Company”) is pleased to report positive results from the independent interpretation of its …
Qintelligence and TradeAssets Sign MOU to Accelerate Digital Finance Innovation
EIN Presswire
·
September 8, 2025
Partnership to Drive DeFi Adoption, Tokenisation, and RegTech Innovation Across Global Trade Finance DUBAI, UNITED ARAB EMIRATES, September 8, 2025 /EINPresswire.com/ -- Qintelligence Commercial Brokers (“Qintelligence”) and Fintech Innovations …
Synaptics to demonstrate how AI-native processing enables MSOs and OTT streamers to deliver new features at IBC 2025
GlobeNewswire
·
September 8, 2025
AMSTERDAM, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) will be at IBC 2025 from September 12-15 with a full program of demonstrations showcasing how embedding artificial intelligence (AI) and AI-native processing in set-top …
Dayforce Flex Work Expands Frontline Contingent Workforce Platform
GlobeNewswire
·
September 8, 2025
MINNEAPOLIS and TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced a major expansion of its Dayforce Flex Work solution. The enhanced …